EGFR and cancer: As illustrated in Figure 6D,E, YQ456 promoted p‐EGFR stability in cancer cells, thereby increasing the aberrant activation of EGFR pathway, leading to oncogene‐induced senescence (OIS), as evidenced by increased p16Ink4a expression and reduced p‐Rb expression.